Patents by Inventor Emil Pfenninger

Emil Pfenninger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemokine receptor antagonists
    Patent number: 8183366
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof: wherein the variants R, R9, Z, X, Q and Y are defined in the specification.
    Type: Grant
    Filed: September 20, 2010
    Date of Patent: May 22, 2012
    Assignee: Novartis AG
    Inventors: Rene Hersperger, Philipp Janser, Emil Pfenninger, Hans J Wuethrich, Wolfgang Miltz
  • Chemokine receptor antagonists
    Publication number: 20110015180
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof: wherein the variants R, R9, Z, X, Q and Y are defined in the specification.
    Type: Application
    Filed: September 20, 2010
    Publication date: January 20, 2011
    Inventors: René Hersperger, Philipp Janser, Emil Pfenninger, Hans Juerg Wuethrich, Wolfgang Miltz
  • Chemokine receptor antagonists
    Patent number: 7858781
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof, wherein the variants R, R9, Z, X, Q and Y are defined in the specification.
    Type: Grant
    Filed: February 10, 2005
    Date of Patent: December 28, 2010
    Assignee: Novartis AG
    Inventors: René Hersperger, Philipp Janser, Emil Pfenninger, Hans Juerg Wuethrich, Wolfgang Miltz
  • Chemokine receptor antagonists
    Publication number: 20070155721
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof, wherein the variants R, R9, Z, X, Q and Y are defined in the specification.
    Type: Application
    Filed: February 10, 2002
    Publication date: July 5, 2007
    Inventors: Rene Hersperger, Philipp Janser, Emil Pfenninger, Hans Wuethrich, Wolfgang Miltz
  • Substituted-9H-pyrrolo[3,4-b]quinolin-9-ones and treatment of allergic conditions with them
    Patent number: 4235907
    Abstract: This invention provides compounds of formula ##STR1## wherein R.sub.1 is hydrogen, alkyl, alkenyl or alkynyl, the multiple bond of which is not adjacent to the nitrogen atom,R.sub.2 is, for example, hydrogen, alkyl, alkoxy, hydroxy or halogen, andR.sub.3 is hydrogen, halogen, hydroxyl, alkyl or alkoxy,useful, for example, in the treatment of allergic asthma.
    Type: Grant
    Filed: April 6, 1979
    Date of Patent: November 25, 1980
    Assignee: Sandoz Ltd.
    Inventor: Emil Pfenninger
  • Hydro-4-phenyl-benz[f]isoindoline compounds
    Patent number: 4171369
    Abstract: The present invention concerns novel hydro-4-phenyl-benz[f]isoindoline derivatives, of the formula ##STR1## wherein R is hydrogen or substituted or unsubstituted alkyl,R.sub.1 and R.sub.2 are hydrogen, halogen or alkyl, and eitherX and Y are hydrogen, orX and Y together are an additional bond,Useful as analgesics and antidepressants.
    Type: Grant
    Filed: March 17, 1975
    Date of Patent: October 16, 1979
    Assignee: Sandoz Ltd.
    Inventors: Roland Achini, Wolfgang Oppolzer, Emil Pfenninger
  • Benz[f]isoindoline compounds
    Patent number: 4164583
    Abstract: The present invention provides benz[f]isoindolines, useful in the treatment of aggression, a process for their preparation and compositions containing these compounds.
    Type: Grant
    Filed: June 22, 1978
    Date of Patent: August 14, 1979
    Assignee: Sandoz Ltd.
    Inventors: Roland Achini, Wolfgang Oppolzer, Emil Pfenninger